IL82654A0 - Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon - Google Patents

Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon

Info

Publication number
IL82654A0
IL82654A0 IL82654A IL8265487A IL82654A0 IL 82654 A0 IL82654 A0 IL 82654A0 IL 82654 A IL82654 A IL 82654A IL 8265487 A IL8265487 A IL 8265487A IL 82654 A0 IL82654 A0 IL 82654A0
Authority
IL
Israel
Prior art keywords
cell carcinoma
recombinant human
basal cell
intralesionally
treatment
Prior art date
Application number
IL82654A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL82654A0 publication Critical patent/IL82654A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL82654A 1986-05-27 1987-05-26 Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon IL82654A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86664486A 1986-05-27 1986-05-27

Publications (1)

Publication Number Publication Date
IL82654A0 true IL82654A0 (en) 1987-11-30

Family

ID=25348060

Family Applications (1)

Application Number Title Priority Date Filing Date
IL82654A IL82654A0 (en) 1986-05-27 1987-05-26 Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon

Country Status (13)

Country Link
EP (1) EP0248583B1 (de)
JP (1) JPS62289526A (de)
KR (1) KR870010871A (de)
AT (1) ATE100717T1 (de)
AU (1) AU601741B2 (de)
CA (1) CA1295243C (de)
DE (1) DE3788899T2 (de)
DK (1) DK264787A (de)
ES (1) ES2061496T3 (de)
IE (1) IE62318B1 (de)
IL (1) IL82654A0 (de)
PH (1) PH26198A (de)
ZA (1) ZA873743B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028422A (en) * 1986-05-27 1991-07-02 Schering Corporation Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
EP0278715A3 (de) * 1987-02-09 1989-03-08 Schering Corporation Verwendung von menschlichem Gamma-Interferon für die Behandlung von Basalzell-Karzinomen
US5256410A (en) * 1988-12-01 1993-10-26 Schering Corporation Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon
DE68908119T2 (de) * 1988-12-01 1993-11-18 Schering Corp Arzneimittel zur Intralesionsbehandlung von schuppenartigem Zellkarzinomen mit rekombinantem human-alpha-Interferon.
IL100415A0 (en) * 1990-12-21 1992-09-06 Schering Corp Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases
US20200038487A1 (en) 2017-03-31 2020-02-06 Accanis Biotech F&E Gmbh & Co Kg Prevention and treatment of non-melanoma skin cancer (nmsc)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3278234D1 (en) * 1981-10-13 1988-04-21 Exovir Inc Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis
WO1983002460A1 (en) * 1982-01-15 1983-07-21 Cetus Corp Interferon-alpha 74
US5098703A (en) * 1982-01-15 1992-03-24 Cetus Corporation Interferon-alpha 76
AU1153083A (en) * 1982-01-15 1983-07-28 Cetus Corporation Interferon-alpha 54
US4822605A (en) * 1986-02-18 1989-04-18 Exovir, Inc. Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like
US4853218A (en) * 1987-02-24 1989-08-01 Schering Corporation Zinc-protamine-alpha interferon complex

Also Published As

Publication number Publication date
PH26198A (en) 1992-03-18
IE871358L (en) 1987-11-27
DK264787A (da) 1987-11-28
CA1295243C (en) 1992-02-04
ATE100717T1 (de) 1994-02-15
KR870010871A (ko) 1987-12-18
EP0248583B1 (de) 1994-01-26
JPS62289526A (ja) 1987-12-16
DK264787D0 (da) 1987-05-25
ZA873743B (en) 1987-11-25
EP0248583A3 (en) 1989-10-18
IE62318B1 (en) 1995-01-25
EP0248583A2 (de) 1987-12-09
DE3788899T2 (de) 1994-05-05
AU7336687A (en) 1987-12-03
AU601741B2 (en) 1990-09-20
ES2061496T3 (es) 1994-12-16
DE3788899D1 (de) 1994-03-10

Similar Documents

Publication Publication Date Title
NZ212632A (en) Tumor necrosis factor, its preparation and its use
DK0433827T3 (da) Cytotoksisk lumfocytmodningsfaktor
NO176665C (no) Fremgangsmåte for fremstilling av ikke-glykosylert IL-6 og vektor for utskillelse derav
IT1183181B (it) Derivati del 3-metil-imidazo(4,5-c)pirazolo con attivita' terapeutica e procedimento per la loropreparazione
GR3031927T3 (en) Cysteine depleted il-6 muteins
NZ227944A (en) Synergistic pharmaceutical composition of a hybrid interferon and a muramylpeptide
ZA873743B (en) Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
ATE67783T1 (de) Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
DK0643973T3 (da) Anvendelse af humant interferon-beta til fremstilling af farmaceutiske præparater til behandling af kronisk myeloid leukæmi
HK46196A (en) Treatment of leukocyte dysfunction with gm-csf
ES2115582T3 (es) Preparacion y aplicaciones de interferon-gamma.
ZA884262B (en) Pharmaceutical composition for the treatment of tumors
GB2179858B (en) Compositions for treating viral skin diseases.
ZA899113B (en) Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon
IL84080A0 (en) Human leukocyte interferon compositions for skin treatment
GR3006999T3 (de)
EP0278715A3 (de) Verwendung von menschlichem Gamma-Interferon für die Behandlung von Basalzell-Karzinomen
HU900202D0 (en) Process for manufacturing of pharmaceutical compositions comprising gamma-interferon suitable to treatment of ovarion cancer

Legal Events

Date Code Title Description
RH Patent void